Articles by : prometheus








Freaky patents: For the lazy crazy

Freaky patents: For the lazy crazy

Prometheus brings you some freaky patents for the lazybones in continuation of our series on freaky patents. Do you have any ideas like these patented ideas?!?! Come to Prometheus to get them patented. One can never say which idea will be commercially successful.

Read More













Freaky Patents: Some seriously funny patents

prometheus

Freaky Patents: Some seriously funny patents

In our previous article we discussed about some freaky patents for the fashion freaks and now in this article we are discussing about some seriously funny patents. Do you have any ideas like these patented ideas?!?! Come to Prometheus to get them patented. One can never say which idea will be commercially successful.

Read More



Protest against Gilead Sciences, an American multinational pharmaceutical company

Hepatitis C patients have been protesting for past one week outside India’s patent office in Dwarka against Gilead Sciences and the United States government for forcing the Indian government “to blindly and speedily grant patents”. IPO is in the process of hearing the company’s patent claim on the drug Sovaldi, with an astounding price of $84,000 (about Rs.57 lakh) in the U.S [more].

Read More






New CRI guidelines issued for Examination of Computer Related Inventions issued by Indian Patent Office

As per the office order dated 19th Feb 2016 issued by the office of the Controller General of Patents, Trademarks and Designs, after having kept in abeyance the guidelines for Examination of Computer Related Inventions have been finalized after having consulted the stakeholders, experts and academic institutions [More]. Our earlier article on draft guidelines with reference to section 3(k) is given here.

Read More


Freaky patents: For the fashion freaks

Freaky patents:  For the fashion freaks

Patents are not all that serious business. Prometheus will bring out a series of articles on freaky patents for our blog readers. Having offbeat ideas like these patented ideas. Come to Prometheus to get them patented. One can never say which idea will be commercially successful.

Read More


A solar energy patent to retired GVSU professor

James Wolter, a retired professor from Grand Valley State University and avid inventor is also a manifold patent winner, and recently received a second patent on his invention for creating a sustainable way to use energy. All his work is aimed at creating healthier energy, with efficient employment and making it more accessible to people all over the world. [more]

Read More


Synchronized Camera Flash Inventor expires at the age of 96

The German inventor of the synchronized camera flash, Artur Fischer, who registered more than 1,100 patents in his lifetime thus beating Thomas Edison passed away in Germany on January 27th, 2016 at the age of 96 years. As per The New York Times, Fischer obtained a patent for the synchronized flash system in 1947 that was developed in his attempt to have his newborn daughter photographed. [more]

Read More


Lilly lost recent round in UK while fighting for Alimta patent battle

Lilly has lost the latest round in an enduring legal fight over patents casing the administration of vitamins in conjunction with its epic lung cancer drug, Alimta (pemexetred). According to UK High Court, Lilly’s Alimta vitamin regimen patent would not be infringed by Allergan marketing its drug in the UK, France, Italy and Spain with instructions to dilute the product only with dextrose solution. [more]

Read More



A CRISPR patent win for a Gene-Editing startup

A patent involving CRISPR has been issued to a biotech startup, Caribou Biosciences in Berkeley, which was co-founded by Jennifer Doudna. The University of California, Berkeley, scientist stated that the CRISPR was invented along with French microbiologist Emmanuelle Charpentier, and the claim was disputed by rival researcher, Feng Zhang of the Broad Institute and the Massachusetts Institute of Technology. Zhang’s CRISPR patents were issued first and are licensed to the recently established public therapeutics company, Editas Medicine, among others. [more]

Read More





Patenting Pedagogy?

A patent application by the Khan Academy in the US has raised serious doubts regarding the patentability of teaching methods. The online education academy has filed an application for patenting their educational videos. [More]

Read More






The first ever smart shoe likely to be developed by Nike

The very novel patent entitled “Athletic performance user interface”, is going to impart a coach under the wearer’s feet in terms of developing a smart shoe by possessing the ability of measuring one’s athletic performance. It is proposed that the shoe will be equipped with sensors to help measure things such as speed, acceleration, direction of motion and things of that nature [more].

Read More


The U.S. Patent and Trademark Office Issuance Of An Additional Notice Of Allowance for Horizon Pharma (HZNP)

Horizon Pharma has announced receiving of a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 14/816,674 (U.S. publication number 2015-0335605), entitled “Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs”. The patent covers Horizon’s U.S. approved medicine RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid. The notice states the substantive examination of the patent application and will only result in the issuance of a U.S. patent after completion of the administrative processes [more].

Read More




Advancement in patent infringement suits over devices

Release of suit against AngioDynamics was not declared by a Delaware district court judge over patents for devices installed below the skin for effortlessness drug delivery. C.R. Bard Inc. stated that AngioDynamics had infringed on patents issued in 2013 and 2014 and AngioDynamics further added the claims as ineligible to be patented due to loss of description of specific items that can be patented [more].

Read More


A Gujarati firm faces patent lawsuit

IIa Technologies Pte Ltd, a synthetic diamond manufacturing company co-founded by Mumbai-based Vishal Mehta is facing litigation from De Beers subsidiary and accused by Element Six Technologies Ltd, for alleged infringement of its patents for proprietary synthetic diamond products. The infringing company was able to produce purest and rarest form of diamond – called type IIa through microwave plasma chemical vapor deposition (MPCVD) process after 8 years of RandD [more].

Read More







Development of robust gene therapy intellectual property portfolio by Renova Therapeutics for treatment of cardiovascular and metabolic diseases

The biopharmaceutical company has attained an elite worldwide license to several patents from the nonprofit Research Development Foundation (RDF), and the company develops gene therapy treatments for congestive heart failure and other chronic diseases. Along with group of patents, Renova Therapeutics’ has expanded its portfolio in the cardiovascular and metabolic disease space, thus imparting future road for its­ paracrine gene therapy product pipeline [more]

Read More


Two US patents granted to Veran Medical Technologies

The granted US patents defend the company’s own 4D respiratory tracking technology, which permits its SPiN Thoracic Navigation System in efficiently tracking a patient’s respiration during navigational procedures. Veran CEO Jason Pesterfield stated that the patented technology (new software) will fundamentally assist lung specialists in targeting solitary pulmonary nodules (SPN’s) and more quickly diagnose patients with lung cancer as compared to several other procedures [more].

Read More





Unification between two of America’s largest, oldest and most research-oriented organizations DuPont and Dow Chemical

The merger, announced in early December, union between two of America’s largest, oldest and most research-oriented organizations and they are set to make huge waves in agriculture, materials and plastics sectors. Before the developments start to happen, DowDuPont will be for a succinct moment be one of the world’s intellectual property powerhouses with respect to patents [more].

Read More




Natco’s settlement of patent case with Gilead covering 30 mg, 45 mg and 75 mg versions of Tamiflu

Natco Pharma Ltd and its partner Alvogen Inc. have settled a patent infringement case with US drug maker Gilead Sciences Inc., and Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ltd and Genentech Inc., thus clearing the way into the world’s largest pharmaceutical market for the Indian drug maker in terms of launching generic versions of anti-influenza drug, Tamiflu [more].

Read More




Utility and PCT patent applications associated with distinctive specifications of cannabinoids by United Cannabis

United Cannabis Corporation has pushed provisional patent application to the next phase in terms of filing a utility patent application and PCT application with the USPTO with respect to unique combinations of pharmaceutically active cannabinoids employed for the treatment of disorders of the nervous system, immune system and cancer

Read More


A third US patent for Cancer Genetics’ proprietary genomic FHACT cancer test

Cancer Genetics Inc., a budding leader in DNA-based cancer diagnostics, proclaimed receiving a third US patent covering FHACT (US patent number 9,157,129), its proprietary FISH (fluorescent in situ hybridization) based HPV associated cancer test and the granted patent is part of a sequence of patents received for FHACT that provide protections for CGI’s proprietary capabilities for the detection of HPV-associated cancers, which include cervical, anal, head and neck, penile, and vulvar cancers.

Read More



Patents for Academic and Research Institutes

prometheus

Patents for Academic and Research Institutes

Patent filing by research institutes promotes their research works actively to the public domain. Since the patents can be licensed, it is therefore possible to derive financial value from them for conducting further researches. As the innovations evolving from institutes come out of strong fundamental knowledge, it is highly recommended to secure the same.

Read More


Sun Pharma Rises After Settling Patent Litigation With Actavis

As part of the agreement, Ranbaxy along with its partners Cipher Pharm and Galephar Pharma, has entered into a non-exclusive license agreement with Actavis under the Dublin-headquartered company may start selling its generic version of Absorica in the US on 27 December 2020 (nine months before the expiration of the patents in September 2021) or earlier under certain circumstances, Sun Pharma said.

Read More





Amid the Patent Wars, an Oasis of Calm Collaboration

The Open Invention Network – led by IBM, Google and 5 others – seeks a patent “no-fly zone” for open-source software. The consortium, known as the Open Invention Network, is dedicated to protecting a mode of collaborative invention. Specifically, it tries to safeguard the Linux open-source software ecosystem—software that’s written collaboratively and distributed for free—from patent licensing demands and lawsuits from any aggressor.

Read More




Inform Genomics Files Provisional Patent Application With United States Patent And Trademark Office (USPTO) -“Systems And Methods For Predicting Treatment-Regimen-Related Outcomes

Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced that the Company has filed a patent for systems and methods for predicting treatment outcomes from chemotherapy.

Read More


And You Thought Planes Were Cramped Now! Airbus Files Patent for Radical Split-Level Mezzanine Seating Design that Would See Passengers Placed on Top of Each Other

One of the world’s leading aeroplane manufacturers has come up with a radical new seat design -with split-level seating inside the cabin.
The arrangement proposed by Airbus designers would be used in a premium cabin such as business class with rows in the middle section alternating between floor level and an elevated level that is several feet higher.

Read More


ALMAC Discovery Secures European Patent Protection for ALM201

Almac Discovery, a research driven oncology company that is dedicated to the discovery and development of novel and innovative approaches to the treatment of cancer, has announced that it has been granted patent protection (Patent Number 2040728) for its novel therapeutic drug, ALM201, in Europe, one of the largest Biopharmaceutical markets in the world. This adds to patent protection already granted in a further 6 countries – Australia, China, Israel, Japan, New Zealand and South Africa, strengthening the company’s growing portfolio globally.

Read More
















Daniel Gurney’s new Internal Combustion Engine patent

Daniel Gurney has done it again. The former racing car driver who has won at Sports car, Formula one, NASCAR and Indy car is also a car manufacturer and team owner. He was the one who started the tradition of spraying champagne while celebrating at the podium and also who placed a simple right angle extension on upper trailing edge of rear wing which increases the down force.

Gurney is now, back along with his team who has patented an engine design called “Moment cancelling 4 stroke”- exclusively designed for motorcycle applications. They aimed to create it which could be simple and compact, also being sturdy and systematic.

The engine design has two cylinders having a crankshaft individually and which turns in opposite direction. According to the theory given, the pistons, crank

Read More



IPO Notifies Trademarks agent examination 2015

The Indian Patent Office has invited applications for the Trade Marks Agent Examination 2015 to be held shortly. The last date for receipt of the applications is 7th Sep 2015. After scrutiny of the applications, the IPO would post the list of eligible candidates and the date of the written exam and interview on or before 11th Sep 2015 in its official website. The written exam and the interview will be held at Mumbai.

Read More




Pluristem granted US Patent for production methods and use of placental cell therapy in a range of indications

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced that the U.S. Patent and Trademark Office has issued to the Company patent 9,096,827 titled “Adherent Cells From Placenta Tissue and Use Thereof in Therapy”. The patent protects specific methods of culturing placental adherent stromal cells, and use of these cells for the treatment of a wide variety of diseases.

Read More




World’s first 3D printed drug approved

The FDA has approved the world’s first 3D printed drug for the treatment of epilepsy. The new drug, Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy. The 3D technology allows Spritam (levetiracetam) to have higher manufacturing precision thus accommodating a higher dose almost upto 1000 mg in each tablet. As each drug will be completely uniform, it also means doses are more consistent.

Although the FDA has previously approved 3D-printed medical devices, this is the first time a 3D-printed product has been approved for use inside the human body.

Spritam is expected to be available in the first quarter of 2016.

Read More


India wins Patent war on Hair Loss formula

prometheus

India successfully protected its traditional knowledge by stalling a leading UK-based laboratory’s move to patent a medicinal composition containing turmeric, pine bark and green tea for treating hair loss.

The UK-based company – Pangaea Laboratories Limited – had filed the patent application in February, 2011. The Traditional Knowledge Digital Library (TKDL) of the Council of Scientific and Industrial Research (CSIR) could manage to prove the European Patent Office (EPO) that turmeric, pine bark and green tea have been used since time immemorial as an effective treatment for hair loss in the indigenous systems like Ayurveda and Unani. Once the patent application was published in the EPO website the CSIR-TKDL unit had objected and filed an evidence on January 13, 2014. Based on India’s evidence, the patent application was finally “deemed to

Read More


Two more feathers of success added to the Patent-Hat of Suven life sciences ltd.

Suven Life Sciences Ltd. from Hyderabad had announced the grant of one product patent from Mexico (No: 325948 and Title: Bicyclic compounds as ligands of the nicotinic receptor beta 2 acetylcholine alpha 4) and one product patent from Singapore (No: 180674 and Title: Bicyclic compounds as alpha-4-beta-2 nicotinic acetylcholine receptor ligands) that cover New Chemical Entities (NCEs) for the treatment of neurodegenerative disorders. The NCEs belong to the class of selective alpha-4-beta-2 compounds, being developed as therapeutic agents for major depressive disorders (MDD).

Read More


Patent acquisition initiative by Google

Google has announced a “Patent purchase promotion” initiative that is an experimental marketplace for patents. Google would open a streamlined portal from May 8, 2015 to May 22, 2015 through which patent holders can submit offers for selling their patents to google. The patent holders can set the price and by June 26, 2015, google would review the patents and let the patent holders know whether it is interested in acquiring the patents.

Read More